Drug combination in vivo using combination index method: Taxotere and T607 against colon carcinoma HCT-116 xenograft tumor in nude mice
Synergy · 2016
DOI: 10.1016/j.synres.2016.06.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synergy, 2016. Verfasst von Jianing Fu und 6 weiteren Autor:innen. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Aventis Pharmaceuticals, Bridgewater, NJ 08807, Tularik, Inc., South San Francisco, CA 94080, SKI Institutional Core Fund, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Aventis Pharmaceuticals, Bridgewater, NJ 08807
- Tularik, Inc., South San Francisco, CA 94080
- SKI Institutional Core Fund, Memorial Sloan-Kettering Cancer Center, New York, NY 10065
Zitieren
APA
Fu, J., Zhang, N., Chou, J. H., Dong, H., Lin, S., Ulrich-Merzenich, G. S., & Chou, T. (2016). Drug combination in vivo using combination index method: Taxotere and T607 against colon carcinoma HCT-116 xenograft tumor in nude mice. Synergy. https://doi.org/10.1016/j.synres.2016.06.001
Vancouver
Fu J, Zhang N, Chou JH, Dong H, Lin S, Ulrich-Merzenich GS, et al. Drug combination in vivo using combination index method: Taxotere and T607 against colon carcinoma HCT-116 xenograft tumor in nude mice. Synergy. 2016. doi:10.1016/j.synres.2016.06.001
BibTeX
@article{Fu2016,
author = {Fu, Jianing and Zhang, Ning and Chou, Joseph H. and Dong, Hua-Jin and Lin, Shu-Fu and Ulrich-Merzenich, Gudrun S. and Chou, Ting-Chao},
title = {Drug combination in vivo using combination index method: Taxotere and T607 against colon carcinoma HCT-116 xenograft tumor in nude mice},
journal = {Synergy},
year = {2016},
doi = {10.1016/j.synres.2016.06.001}
}
EUVIMED